Sluyter, Ronald

Associate Professor

  • Illawarra Health and Medical Research Institute
  • Faculty of Science, Medicine and Health
  • School of Biological Sciences
  • Molecular Horizons
  • Head - Immunology and Cell Signalling

Top Publications


    Year Title
    2017 The P2X7 Receptor
    2014 The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
    Published in   Pharmacological Reviews
    2013 P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia
    Published in   Mediators of Inflammation

Research Overview


  • Ronald Sluyter is Head of the Immunology and Cell Signalling Group. His group explores the roles P2X7 and other purinergic molecules in human and veterinary health and disease including motor neurone disease, pain, graft-versus-host disease and cancer.

Selected Publications


Investigator On


Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy The Role of Purinergic Signalling in Inflammatory Disorders Geraghty, Nicholas
    Doctor of Philosophy Characterisation of P2X4 and P2Y12 receptors in humans and companion animals Sophocleous, Reece
    Doctor of Philosophy Mapping Programmed cell death of neutrophils in response to Group A Streptococcal infection Williams, Jonathan
    Doctor of Philosophy Therapeutics Strategies to Prevent Graft-versus-Host Disease Adhikary, Sam
    Doctor of Philosophy Next Generation Sunscreen Products Optimised for Australian Conditions Morlando, Alexander
    Doctor of Philosophy Characterising the Interaction Between Group A Streptococcus and Hyaluronin McEwan, Tahnee
    Doctor of Philosophy The P2X7 Receptor in Inflammation and Disease Cuthbertson, Peter

Professional Service Activities


Full Name


  • Ronald Sluyter

Mailing Address


  • Room 32.309, IHMRI (Bldg 32)

    University of Wollongong

    Wollongong

    NSW

    2522

    Australia

Top Publications


    Year Title
    2017 The P2X7 Receptor
    2014 The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease
    Published in   Pharmacological Reviews
    2013 P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia
    Published in   Mediators of Inflammation

Research Overview


  • Ronald Sluyter is Head of the Immunology and Cell Signalling Group. His group explores the roles P2X7 and other purinergic molecules in human and veterinary health and disease including motor neurone disease, pain, graft-versus-host disease and cancer.

Selected Publications


Investigator On


Advisees


  • Graduate Advising Relationship

    Degree Research Title Advisee
    Doctor of Philosophy The Role of Purinergic Signalling in Inflammatory Disorders Geraghty, Nicholas
    Doctor of Philosophy Characterisation of P2X4 and P2Y12 receptors in humans and companion animals Sophocleous, Reece
    Doctor of Philosophy Mapping Programmed cell death of neutrophils in response to Group A Streptococcal infection Williams, Jonathan
    Doctor of Philosophy Therapeutics Strategies to Prevent Graft-versus-Host Disease Adhikary, Sam
    Doctor of Philosophy Next Generation Sunscreen Products Optimised for Australian Conditions Morlando, Alexander
    Doctor of Philosophy Characterising the Interaction Between Group A Streptococcus and Hyaluronin McEwan, Tahnee
    Doctor of Philosophy The P2X7 Receptor in Inflammation and Disease Cuthbertson, Peter

Professional Service Activities


Full Name


  • Ronald Sluyter

Mailing Address


  • Room 32.309, IHMRI (Bldg 32)

    University of Wollongong

    Wollongong

    NSW

    2522

    Australia